Skip to main content
ECS BOTANICS HOLDINGS LTD logo

ECS BOTANICS HOLDINGS LTD — Investor Relations & Filings

Ticker · ECS ISIN · AU0000052490 LEI · 254900F6I1ORKXFIGD77 ASX Agriculture, forestry and fishing
Open in API
Filings indexed 913 across all filing types
Latest filing 2021-03-25 Capital/Financing Update
Country AU Australia
Listing ASX ECS

About ECS BOTANICS HOLDINGS LTD

https://ecs-botanics.com/

ECS Botanics Holdings Ltd specializes in the large-scale cultivation and manufacture of medicinal cannabis products. The company utilizes organic and sustainable farming practices, including regenerative agriculture, to produce high-quality cannabis flower and oils. Its operations integrate advanced greenhouse technology with outdoor cultivation to ensure cost-effective production. The product portfolio includes a range of pharmaceutical-grade dried flowers and extracted oils tailored for medical applications. Serving both domestic and international markets, the company focuses on supplying GMP-compliant products to healthcare providers and pharmaceutical distributors. By leveraging low-cost production models and environmentally conscious methodologies, the organization maintains a competitive position in the global medicinal supply chain.

Recent filings

Filing Released Lang Actions
Entitlement Offer - Letter to Eligible Shareholders 3 pages 202.8KB
Capital/Financing Update Classification · 100% confidence The document is a letter to shareholders regarding an entitlement offer of new shares by ECS Botanics Holdings Ltd. It details the terms of the offer, key dates, use of funds, and instructions for shareholders to participate. The content focuses on a capital raising event through a pro rata entitlement offer, including issue price, record date, closing date, and allocation details. There is no financial statement or comprehensive financial report included, nor is it a regulatory announcement of a report publication. The document is clearly an update on a financing activity related to share issuance and capital raising. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail support a confident classification.
2021-03-25 English
Supply Agreement with Releaf Dispensaries 2 pages 203.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 25 March 2021, detailing a supply agreement between ECS Botanics Holdings Ltd and Releaf Dispensaries. It discusses the terms of the agreement, expected revenue, and business context. There are no financial statements, regulatory certifications, or detailed financial performance data. The content focuses on a business update related to a supply contract, which fits the category of a Capital/Financing Update or general business update. However, since it is specifically about a supply agreement expected to generate revenue, it aligns best with Capital/Financing Update (CAP). The document length is about 5246 characters, which is sufficient for a substantive announcement but does not contain financial report data. Therefore, the classification is CAP with high confidence.
2021-03-24 English
Secondary Trading Notice & Appendix 2A 15 pages 438.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 24 March 2021, titled 'Secondary Trading Notice' and includes an Appendix 2A form which is an application for quotation of securities. It references the Corporations Act 2001 and details the issuance of 80,000,000 fully paid ordinary shares pursuant to a share placement. The document is regulatory in nature, providing notice of securities issued without disclosure and compliance with relevant sections of the Act. It does not contain financial statements, earnings data, management discussion, or other report content. It is a formal regulatory announcement related to capital raising and securities issuance, specifically an application for quotation of securities on the ASX. This fits the category of Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes.
2021-03-23 English
Typographical Correction in Entitlement Offer Prospectus 1
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 23 March 2021 from ECS Botanics Holdings Ltd. It addresses a correction to a typographical error in the Entitlement Offer Prospectus, specifically clarifying the rounding rule for fractional entitlements. The document is short (1949 characters) and focuses on correcting a detail in a previously issued prospectus related to an entitlement offer, which is a capital raising activity. There is no financial data, no full report, no voting results, no management changes, or other report types. This is an update related to capital raising documentation, specifically a correction to a prospectus for an entitlement offer, which falls under capital/financing updates. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2021-03-22 English
Proposed issue of Securities - ECS 6 pages 31.3KB
Capital/Financing Update Classification · 100% confidence The document is an announcement regarding a proposed issue of securities by ECS Botanics Holdings Ltd. It details the type of issue (standard pro rata issue), number of securities to be issued, offer price, timetable, fees, and purpose of the funds raised. There are no financial statements or detailed financial performance data included. The content focuses on the capital raising activity and the terms of the securities issuance. This matches the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and capital structure changes.
2021-03-17 English
Entitlement Offer Prospectus 40 pages 751.4KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Prospectus' and relates to a non-renounceable entitlement issue of new shares by ECS Botanics Holdings Ltd. It details the offer terms, risk factors, timetable, and instructions for shareholders to participate in the capital raising. The document is a formal offer document for raising capital through issuing new shares, which fits the definition of a Capital/Financing Update. It is not an annual report, earnings release, or any other report type. The length and content confirm it is the actual prospectus, not just an announcement of a report. Therefore, the correct classification is Capital/Financing Update (CAP).
2021-03-17 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.